Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc.MTNB · Entity 8443 | Director | September 07, 2017 | September 07, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Matinas BioPharma Holdings, Inc.
Report date September 07, 2017 · Filed September 07, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 203,984 |
Reported balance
After 2017-09-07 transaction · row 1
1 source rowRow 1 · 2017-09-07 · Purchase · Acquired 5,000 · Balance 203,984 |
| Common StockSEC Table I · non-derivative | IndirectHeld by 1010 Holdings LLC | 351,563 |
Reported balance
Holding disclosure · report date 2017-09-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 351,563 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2017 Filed Sep 7, 2017 21:13 UTC | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | PurchaseCommon Stock | 5,000 | $1.24 | $6,200.00 |
DisclosureSEC source: 0000905718-17-000827 · ferrari_form4sep72017.xml · nonDerivative · entry 1 FERRARI STEFANO · CIK 0001588237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,984 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.